Founded in 2006, Affinity Biosciences is a pioneering Life Science and High-Tech company whose biochemical products and services are mainly applied in biotechnology, medical research and pharmaceutical development. Aside from being the major supplier of innovative tools for signaling transduction research, Affinity Biosciences also offers a vast variety of more than 500 inhibitors and SiRNA. So far, Affinity Biotech has successfully developed more than 13,000 categories of antibodies, and have more than 15,000 kinds of peptides in stock.
Affinity biosciences offers:
Quality assurance at Affinity Biosciences is of utmost significance that Affinity Biosciences cannot afford to lose. Our quality peptide design is essential to generating specific, selective, and reproducible antibodies first thing. Affinity Biosciences uses synthetic peptide haptens or recombinant protein to produce antibodies with expertise and proficiency from the beginning, thereby allowing product quality to be under close control while enabling us to target particular protein regions and isoforms.